Use real world evidence to spot trends and satisfy the patient needs of tomorrow.

The smartest companies are seeing the future. By adopting data as the backbone of the company and overhauling entire business models across the lifecycle, some pharma companies are beginning to identify trends and opportunities before payers and regulators, before physicians, and before even their own colleagues who haven’t yet got access.

Speakers from Sanofi, Novartis, GSK and more will share their experiences of RWE and data-led methodology and explain how your company can gather, share and analyse real world data in order to make greater, more accurate predictions into the patient world of tomorrow. 

A snapshot of the speaker line-up:

  • Michael Seewald
    Michael SeewaldVP & Global Head Real World Evidence
    Novartis
  • Chris Chinn
    Chris Chinn Head of Real World Investigations
    Sanofi
  • David Leather
    David Leather Medical VP Global Respiratory Franchise and Salford Lung Study Lead
    GSK
  • Tra-Mi Phan
    Tra-Mi PhanVP Medical & Scientific Affairs Europe
    Novo Nordisk
  • Anne-Toni Rodgers
    Anne-Toni Rodgers Global Head Operations Payer & Real World Evidence
    AstraZeneca
  • Martin Price
    Martin Price VP Health Economics & Market Access
    Janssen
  • Rob Thwaites
    Rob ThwaitesSenior Director-Strategy, Global Outcomes Research and Head, GI, Global Outcomes Research
    Takeda
  • Pam Bacon
    Pam Bacon Executive Director, Medical Affairs
    Celgene
  • Janet Valentine
    Janet ValentineDirector of the Clinical Practise Research Datalink
    CPRD
  • Barbara Jaszewski
    Barbara Jaszewski VP Global Pricing and Market Access
    Lundbeck


You will learn how to:

  • Win over payers with flawless RWE value execution
  • Discover RWE’s place in your organisation and unlock its true strategic potential
  • Predict future patient trends to meet payer needs and create long-term partnerships
  • Maximise your data’s value – communicate your real world looking glass across departments
  • Illuminate the patient journey to demonstrate why you’re the answer to market needs

Our Track-Record of Proven Success

Conferences promise a lot - we know. Below are a few takeaways from the last year's Summit highlighting the valuable insights the attendees took away …

  • call our sessions essential
  • said they will likely return again next year
  • rated the program very well run

What our delegates have said: 

  • Bayer

    "This was one of the most relevant and comprehensive conferences, which I have attended in recent years. The speakers and meeting chairs were well selected."

    Karel Mechelse, Market Access Strategy Leader, Bayer
  • Novartis

    "Well worth investing in... a place to exchange views and perspectives"

    Frederic de Reydet, Global Market Access Director, Novartis
  • Eli-Lilly

    "An excellent representation of key European decision makers"

    Myriam Zylberman, Senior Director - EU Payer Strategy, Eli Lilly
  • Janssen

    "A fascinating meeting of diverse speakers who outlined numerous themes around the need to prove the validity and trustworthiness of RWE, versus RCTs, with an emphasis on “real time” versus “real world”. Thank you eyeforpharma!"

    Nigel Hughes, Scientific Director, Janssen

Got a question? Get in touch below!

James Mackintosh

James Mackintosh

Global Project Director
eyeforpharma
+1800 814 3459 x7163 (US)
+44 (0) 207 375 7163 (Global)
Email: jmackintosh@eyeforpharma.com

2017 Sponsors & Exhibitors

Gold Sponsors

  • bdd
  • Deloitte
  • Epsilon
  • ERT
  • Ignite Data
  • INC Research
  • Kinapse
  • QuintileIMS
  • Synergus